The Patent Finder

Chronix Biomedical

10 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 13, 2027
    The maintenance fee for Analyzing Circulating Nucleic Acids to Identify a Biomarker Representative of Cancer Presented by a Patient Population (US 10,378,064) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Identifaction of Cancer Biomarkers by Alignment of Nucleic Acid Sequences (US 11,859,251) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 1 fee due Aug 25, 2027
    The maintenance fee for Methods of Quantifying Cell-Free DNA (US 10,570,443) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,047,397Breast Cancer Associated Circulating Nucleic Acid Biomarkers
In force
 · High confidence
In forceHigh confidence
US 10,378,064Analyzing Circulating Nucleic Acids to Identify a Biomarker Representative of Cancer Presented by a Patient Population
In force
 · High confidence
In forceHigh confidence
US 11,859,251Identifaction of Cancer Biomarkers by Alignment of Nucleic Acid Sequences
In force
 · High confidence
In forceHigh confidence
US 11,377,695Breast Cancer Associated Circulating Nucleic Acid Biomarkers
In force
 · High confidence
In forceHigh confidence
US 11,414,706A Method of Determining a Numeric Index of Tumor-Associated Copy Number Changes of Circulating Nucleic Acids Associated with Prostate Cancer
In force
 · High confidence
In forceHigh confidence
US 9,909,186Personalized Biomarkers for Cancer
In force
 · High confidence
In forceHigh confidence
US 11,155,872Detection and Quantification of Donor Cell-Free DNA in the Circulation of Organ Transplant Recipients
In force
 · High confidence
In forceHigh confidence
US 10,214,775Prostate Cancer Associated Circulating Nucleic Acid Biomarkers
In force
 · High confidence
In forceHigh confidence
US 10,570,443Methods of Quantifying Cell-Free DNA
In force
 · High confidence
In forceHigh confidence
US 12,359,252Colorectal Cancer Associated Circulating Nucleic Acid Biomarkers
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 4 abandoned · 8 no status recorded

Showing 1 to 10 of 18, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/270,226Colorectal Cancer Associated Circulating Nucleic Acid BiomarkersJul 15, 2025Pending
18/696,933Methods for Bias-Free Quantification of RnaSep 28, 2022Pending
17/888,353Prostate Cancer Associated Circulating Nucleic Acid BiomarkersAug 15, 2022Pending
17/850,889Breast Cancer Associated Circulating Nucleic Acid BiomarkersJun 27, 2022Pending
17/503,056Detection and Quantification of Donor Cell-Free DNA in the Circulation of Organ Transplant RecipientsOct 15, 2021Pending
17/914,933Mar 25, 2021No status recorded
16/284,963Prostate Cancer Associated Circulating Nucleic Acid BiomarkersFeb 25, 2019Pending
14/799,989Prostate Cancer Associated Circulating Nucleic Acid BiomarkersJul 15, 2015Abandoned
14/893,807Detection and Quantification of Donor Cell-Free DNA in the Circulation of Organ Transplant RecipientsMay 29, 2014Abandoned
14/352,826Colorectal Cancer Associated Circulating Nucleic Acid BiomarkersOct 19, 2012Abandoned
10 of 18 applications shown.
Pro members see all 18 published applications.
Pro members: see all 18 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited